Systemic autoimmune disease as a cause of death: mortality burden and comorbidities

Author:

Mitratza Marianna1ORCID,Klijs Bart12,Hak A Elisabeth3,Kardaun Jan W P F12,Kunst Anton E1

Affiliation:

1. Department of Public and Occupational Health, Academic Medical Center, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands

2. Department of Health and Care, Statistics Netherlands, The Hague, the Netherlands

3. Department of Rheumatology and Clinical Immunology, Academic Medical Center, Amsterdam UMC, Amsterdam Rheumatology and Immunology Center, Amsterdam, the Netherlands

Abstract

Abstract Objectives Systemic autoimmune diseases (SAIDs) have chronic trajectories and share characteristics of self-directed inflammation, as well as aspects of clinical expression. Nonetheless, burden-of-disease studies rarely investigate them as a distinct category. This study aims to assess the mortality rate of SAIDs as a group and to evaluate co-occurring causes of death. Methods We used death certificate data in the Netherlands, 2013–2017 (N = 711 247), and constructed a SAIDs list at the fourth-position ICD-10 level. The mortality rate of SAIDs as underlying cause of death (CoD), non-underlying CoD, and any-mention CoD was calculated. We estimated age-sex-standardized observed/expected (O/E) ratios to assess comorbidities in deaths with SAID relative to the general deceased population. Results We observed 3335 deaths with SAID on their death certificate (0.47% of all deaths). The mortality rate of SAID was 14.6 per million population as underlying CoD, 28.0 as non-underlying CoD, and 39.7 as any-mention CoD. The mortality rate was higher for females and increased exponentially with age. SAID-related deaths were positively associated with all comorbidities except for solid neoplasms and mental conditions. Particularly strong was the association with diseases of the musculoskeletal system (O/E = 3.38; 95% CI: 2.98, 3.82), other diseases of the genitourinary system (O/E = 2.73; 95% CI: 2.18, 3.38), influenza (O/E = 2.71; 95% CI: 1.74, 4.03), blood diseases (O/E = 2.02; 95% CI: 1.70, 2.39), skin and subcutaneous tissue diseases (O/E = 1.95; 95% CI: 1.54, 2.45), and infectious diseases (O/E = 1.85; 95% CI: 1.70, 2.01). Conclusion Systemic autoimmune diseases constitute a rare group of causes of death, but contribute to mortality through multiple comorbidities. Classification systems could be adapted to better encompass these diseases as a category.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Reference46 articles.

1. Google-driven search for big data in autoimmune geoepidemiology: analysis of 394,827 patients with systemic autoimmune diseases (review);Ramos-Casals;Autoimmun Rev,2015

2. Autoimmunity and autoinflammation: a systems view on signaling pathway dysregulation profiles;Arakelyan;PLoS One,2017

3. A proposed classification of the immunological diseases;McGonagle;PLoS Med,2006

4. Clinical implications of shared genetics and pathogenesis in autoimmune diseases (review);Zhernakova;Nat Rev Endocrinol,2013

5. Omics studies: their use in diagnosis and reclassification of SLE and other systemic autoimmune diseases (review);Teruel;Rheumatology (Oxford),2017

Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Uveitis and Scleritis as a Risk Factor for Mortality;Ocular Immunology and Inflammation;2024-01-10

2. All-Cause and Cause-Specific Mortality among Patients with Vitiligo: A Nationwide Population-Based Study in Korea;Journal of Investigative Dermatology;2024-01

3. Mortality Causes of Autoimmune Rheumatic Diseases;Causes and Diagnosis of Autoimmune Diseases [Working Title];2023-12-15

4. Estimating mortality in rare diseases using a population-based registry, 2002 through 2019;Orphanet Journal of Rare Diseases;2023-11-17

5. Imaging and monitoring of granzyme B in the immune response;WIREs Nanomedicine and Nanobiotechnology;2023-09-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3